title: Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
abstract: BACKGROUND
  Polycystic ovary syndrome (PCOS) is characterized by chronic anovulation, hyperandrogenemia and insulin resistance. Hyperreninemia is observed in insulin resistance and hyperandrogenemic states.
  
  
  OBJECTIVE
  To investigate the levels of total plasma renin and their possible relationship with insulin resistance and hyperandrogenemia and to explore the effect of metformin on these parameters in PCOS women.
  
  
  METHODS
  48 PCOS women who were age- and body mass index (BMI)-matched with 21 healthy women were studied. Total renin, aldosterone levels, glucose and insulin levels were measured at basal state and during an oral glucose tolerance test in all subjects. A subgroup of women with PCOS was evaluated 6 months after metformin administration.
  
  
  RESULTS
  Total renin levels were significantly higher in PCOS women compared to controls. PCOS women compared to controls displayed higher areas under the curve for glucose, insulin and total renin (AUCREN). Mean AUCREN was correlated significantly with insulin resistance indices and positively with free testosterone levels. Total renin, aldosterone, androgen levels and insulin sensitivity indices were significantly improved after 6 months on metformin treatment.
  
  
  CONCLUSIONS
  PCOS women demonstrated an insulin resistance and hyperandogenemia-related increase in serum total renin levels. Metformin treatment was shown to significantly reduce total renin levels.
authors.affiliation: First Department of Internal Medicine, Laiko General Hospital, Athens, Greece. akandara@otenet.gr
authors.forename: Evanthia
authors.initials: E
authors.lastname: Diamanti-Kandarakis
authors.forename: Frangiskos N
authors.initials: FN
authors.lastname: Economou
authors.forename: Sarantis
authors.initials: S
authors.lastname: Livadas
authors.forename: Evangelia
authors.initials: E
authors.lastname: Tantalaki
authors.forename: Christina
authors.initials: C
authors.lastname: Piperi
authors.forename: Athanasios G
authors.initials: AG
authors.lastname: Papavassiliou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Panidis
mesh_terms: D000328:Adult; D000450:Aldosterone / Q000097:blood; D000728:Androgens / Q000097:blood; D019540:Area Under Curve; D001786:Blood Glucose; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008687:Metformin / Q000008:administration & dosage*; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy*; D012083:Renin / Q000097:blood* / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D000728:Androgens; D001786:Blood Glucose; D007328:Insulin; D000450:Aldosterone; D008687:Metformin; D012083:Renin